57 related articles for article (PubMed ID: 8381187)
1. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group.
Feld R; Rubinstein L; Thomas PA
J Natl Cancer Inst; 1993 Feb; 85(4):299-306. PubMed ID: 8381187
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of adjuvant therapy for cisplatin-unfit patients with non-small-cell lung cancer: A multicenter analysis.
Noritake O; Nakamura S; Kinoshita F; Aokage K; Asao T; Matsuura Y; Chen-Yoshikawa TF
Lung Cancer; 2024 Feb; 188():107470. PubMed ID: 38237212
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy after complete resection of non-small cell lung cancer.
Laack E; Bokemeyer C; Hossfeld DK
Dtsch Arztebl Int; 2008 Apr; 105(14):249-54. PubMed ID: 19629205
[TBL] [Abstract][Full Text] [Related]
4. Clustered circulating tumor cells as a predictor of adjuvant-chemotherapy efficacy in lung cancer.
Sawabata N; Hamaji M; Yoshikawa D; Miyata R; Kawaguchi T
Ann Thorac Surg; 2024 May; ():. PubMed ID: 38789007
[TBL] [Abstract][Full Text] [Related]
5. 3-Heptylidene-4,6-Dimethoxy-3
das Neves SC; de Araújo FH; Correa WA; Martins ACF; Coelho HRS; Vilela MLB; do Nascimento VA; Kassuya CAL; de Lima DP; Beatriz A; Oliveira RJ; Gomes RDS
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770711
[TBL] [Abstract][Full Text] [Related]
6. Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery.
Donington JS; Martin LW
J Thorac Cardiovasc Surg; 2019 Jul; 158(1):287-288. PubMed ID: 31248513
[No Abstract] [Full Text] [Related]
7. For a better adjuvant strategy for resected lung cancer-lessons from treatment failure patterns of the ADJUVANT trial (CTONG 1104).
Suda K
Transl Lung Cancer Res; 2019 Dec; 8(Suppl 4):S395-S399. PubMed ID: 32038923
[No Abstract] [Full Text] [Related]
8. Study-design of adjuvant chemotherapy for lung cancer: A cart before the horse.
Takahashi T
Ann Thorac Surg; 2024 Apr; ():. PubMed ID: 38621654
[No Abstract] [Full Text] [Related]
9. Biphasic JNK-Erk signaling separates the induction and maintenance of cell senescence after DNA damage induced by topoisomerase II inhibition.
Netterfield TS; Ostheimer GJ; Tentner AR; Joughin BA; Dakoyannis AM; Sharma CD; Sorger PK; Janes KA; Lauffenburger DA; Yaffe MB
Cell Syst; 2023 Jul; 14(7):582-604.e10. PubMed ID: 37473730
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer.
Chen YY; Wang LW; Wang SY; Wu BB; Wang ZM; Chen FF; Xiong B
Onco Targets Ther; 2015; 8():2033-43. PubMed ID: 26346974
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.
Wei Y; Royston P; Tierney JF; Parmar MK
Stat Med; 2015 Sep; 34(21):2881-98. PubMed ID: 26099573
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Burdett S; Pignon JP; Tierney J; Tribodet H; Stewart L; Le Pechoux C; Aupérin A; Le Chevalier T; Stephens RJ; Arriagada R; Higgins JP; Johnson DH; Van Meerbeeck J; Parmar MK; Souhami RL; Bergman B; Douillard JY; Dunant A; Endo C; Girling D; Kato H; Keller SM; Kimura H; Knuuttila A; Kodama K; Komaki R; Kris MG; Lad T; Mineo T; Piantadosi S; Rosell R; Scagliotti G; Seymour LK; Shepherd FA; Sylvester R; Tada H; Tanaka F; Torri V; Waller D; Liang Y;
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD011430. PubMed ID: 25730344
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for resected non-small cell lung cancer.
Wozniak AJ; Gadgeel SM
Ther Adv Med Oncol; 2009 Sep; 1(2):109-18. PubMed ID: 21789116
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.
; Arriagada R; Auperin A; Burdett S; Higgins JP; Johnson DH; Le Chevalier T; Le Pechoux C; Parmar MK; Pignon JP; Souhami RL; Stephens RJ; Stewart LA; Tierney JF; Tribodet H; van Meerbeeck J
Lancet; 2010 Apr; 375(9722):1267-77. PubMed ID: 20338627
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for non-small cell lung cancer.
Crane EJ; Simon G
Curr Treat Options Oncol; 2006 Jan; 7(1):51-8. PubMed ID: 16343368
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for resected non-small-cell lung cancer: past, present, and future.
Juergens RA; Brahmer JR
Curr Oncol Rep; 2005 Jul; 7(4):248-54. PubMed ID: 15946582
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.
Lin TL; Brahmer JR
Curr Oncol Rep; 2004 Jul; 6(4):251-8. PubMed ID: 15161575
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for non-small cell lung cancer.
Non-small Cell Lung Cancer Collaborative Group
Cochrane Database Syst Rev; 2000; 2000(2):CD002139. PubMed ID: 10796867
[TBL] [Abstract][Full Text] [Related]
19. New prognostic factors in resectable non-small cell lung cancer.
Smit EF; Groen HJ; Splinter TA; Ebels T; Postmus PE
Thorax; 1996 Jun; 51(6):638-46. PubMed ID: 8693450
[No Abstract] [Full Text] [Related]
20. Postoperative chemotherapy for resected non-small-cell lung cancer.
Crump M
World J Surg; 1993; 17(6):735-40. PubMed ID: 8109110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
